Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Elects Linda McGoldrick to Board of Directors

WILMINGTON, Mass., Jun 4, 2004 (BUSINESS WIRE) -- Charles River Laboratories International Inc. (NYSE:CRL), a leading provider of pre-clinical research products and services to pharmaceutical and biotechnology companies as well as academia and government announces the election of Linda McGoldrick to its Board of Directors effective immediately.

James C. Foster, Chairman, President and Chief Executive Officer of Charles River, stated, "Linda brings strong analytical skills, and a strategic healthcare background to our already diverse board. We welcome her insights, expertise and energy."

Ms. McGoldrick is Chairman of Financial Health Associates International, a healthcare management consulting concern, which she founded in 1985. From 2001 to 2003, she served as Senior Vice President and National Development Director for the Healthcare and Life Sciences Industry Practices at Marsh-MMC Companies. Ms. McGoldrick served as Board Member and International Operations and Marketing Director of Veos plc, a European medical devices company from 1999 to 2001 and was Managing Director Europe for Kaiser Permanente International. She serves on the Boards of Axis Shield Group plc, a pan Nordic and European diagnostics company, and served CraneWare Ltd, and Cask Solutions, Inc., UK and USA healthcare software companies.

Ms. McGoldrick holds an MBA degree from the Wharton School of Business and an MSW degree in healthcare from the University of Pennsylvania.

About Charles River Laboratories

Charles River Laboratories, based in Wilmington, Massachusetts, is a leading provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. The Company is the global leader in providing the animal research models required in research and development for new drugs, medical devices and therapies. The Company also offers a broad and growing portfolio of products and services that enable customers to reduce costs, enhance productivity in drug discovery and development, and increase speed to market. Charles River's customer base spans over 50 countries, and includes all of the major pharmaceutical companies, biotechnology companies, and many leading hospitals, academic and government institutions.

Find out more about Charles River Laboratories at: www.criver.com

SOURCE: Charles River Laboratories International Inc.

Charles River Laboratories International Inc.
Elizabeth Ferber, 978-658-6000, ext. 1693
corpcomm@criver.com

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)